A possible therapeutic solution for treating ALT tumors has been identified in the IFOM laboratories, which include for example glioblastoma and osteosarcoma and against which chemotherapy and radiotherapy are not very effective. It is a therapy based on Antisense Oligonucleotides that acts on RNAs that promote the longevity of cancer cells of this type of […]
Tuesday, November 21th, 2023 Aula “A.Falaschi” IGM LLCS di Pavia Time 15:00 Giulia Monticone Louisiana Cancer Research Center at LSU Health Sciences Center, New Orleans (US) It’s time to wake up: awakening protective immunity with adenosine-based immunotherapy
It is a pleasure to welcome Maria Michela Pallotta to our team at the Institute of Molecular Genetics of the CNR in Pavia. Maria Michela joins us as a researcher in the PNRR call “One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases,” with a focus on the topic “Emerging […]
Tuesday 10 OTTOBRE 2023 Aula “A.Falaschi” IGM LLCS di Pavia Time 14:30 Cristina Belgiovine Università di Pavia – Policlinico San Matteo Pavia Fondazione IRCCS Role of immune response in tumor and prosthetic microenvironment
With the publication of the rankings on 31 July, the evaluation procedure for the projects of the Italian Science Fund of the Ministry of University and Research, FIS 2021, was concluded. The FIS call aims to support fundamental research projects at national level, similar to those funded by the European Research Council (ERC). Thanks to […]
Although several progresses have been made in terms of diagnosis, treatment and prevention since the first cases in December 2019, it is still not clear why SARS-CoV-2 has such a dramatic impact on human health compared to other respiratory viruses. The IFOM group led by Fabrizio d’Adda di Fagagna, specialized for 20 years in the […]
Tuesday March 14th 2023 Conference Room “A.Falaschi” IGM LLCS di Pavia TIME: 14:30 Pietro Luigi Mauri Head of Proteomics Laboratory – ITB CNR Proteomics for biomarker and target discovery – Translational and Fundamental Investigations Guest: Giovanni Maga
Tuesday March 7th 2023 Conference Room “A.Falaschi” IGM LLCS di Pavia TIME: 14:30 Anna Villa Istituto di Ricerca Genetica e Biomedica IRGB CNR – Head of “Pathogenesis and Treatment of immune and bone disease” at Telethon Institute for Gene Therapy, San Raffaele, Milan, Italy Advances in Pathophysiology and treatment of RAG defects Guest: Giovanni Maga
July 7th 2022 – at 14:30 Silvia Bione Dissecting the role of GC-AG introns in gene expression regulation